Skip to main content

Table 2 Perspectives about qualities of the information received on the 13vPCV supplementary dose program from survey respondents (n = 120)

From: Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings

 

Agree n (%)

Neutral n (%)

Disagree n (%)

Timely

93 (77)

7 (6)

21 (17)

Sufficient

102 (86)

8 (7)

8 (7)

Easy to access

101 (87)

11 (10)

4 (3)

Clear

109 (93)

5 (4)

4 (3)